Search results
Author(s):
Ton Duy Mai
,
Tri Huynh Quang Ho
,
Sy Van Hoang
,
et al
Added:
7 months ago
Author(s):
Shirley Siang Ning Tan
,
Wei Hong Lai
,
Lee Len Tiong
,
et al
Added:
4 months ago
Author(s):
Monika Bhandari
,
Akshyaya Pradhan
,
Pravesh Vishwakarma
,
et al
Added:
9 months ago
Author(s):
Apisara Lohachatinante
,
Nuttanun Kittikunkanyakit
,
Sayamon Sukkha
,
et al
Added:
1 year ago
Author(s):
Yugo Yamashita
Added:
2 years ago
ESC 23 — In this concise interview, Dr Yugo Yamashita (Kyoto University Graduate School of Medicine, JP) reveals the findings of the ONCO DVT Study (NCT03895502).
The ONCO DVT study (Takeshi Morimoto) aimed to determine the ideal duration of anticoagulation therapy with the direct oral anticoagulant (DOAC) edoxaban for the treatment of isolated distal deep vein thrombosis (IDDVT) in patients…
View more
Author(s):
Kazuya Hosokawa
,
Abe Kotaro
Added:
2 years ago
AHA 2023 — Dr Kazuya Hosokawa and Dr Abe Kotaro (Kyushu University Hospital, JP) join us to share the findings of the KABUKI trial (NCT04730037). The aim of KABUKI (Daiichi Sankyo) is to assess whether edoxaban, a direct factor Xa inhibitor, is noninferior to warfarin in preventing worsening of chronic thromboembolic pulmonary hypertension (CTEPH).This investigator-initiated, multicenter, phase 3…
View more
Author(s):
Tri Huynh Quang Ho
,
Minh That Ton
,
Viet Lan Nguyen
,
et al
Added:
1 year ago
Author(s):
Minh That Ton
,
Tri Huynh Quang Ho
,
Viet Lan Nguyen
,
et al
Added:
1 year ago
Author(s):
Maki Komiyama
,
Moritake Iguchi
,
Hiromichi Wada
,
et al
Added:
1 year ago